Skip to main content
Clinical Trials/NL-OMON48381
NL-OMON48381
Recruiting
Not Applicable

PRegnancy Outcomes and Maternal Insulin Sensitivity - PROMIS

niversitair Medisch Centrum Groningen0 sites130 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
130
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Healthy singleton pregnant women (10\-12 weeks of gestation)
  • \- BMI \*25 kg/m2
  • \- Fasting Blood Glucose (FBG \*7\.0 mmol/l)
  • \- Dutch or English speaking
  • \- Written informed consent

Exclusion Criteria

  • \- Serious health complications (Hypertension, Hyperlipidemia, Asthma, Haemochromatosis) or medication use that influence the glucose metabolism or fetal growth (e.g. corticosteroids).
  • \- Multiple pregnancy
  • \- pre\-existing Diabetes type 1 and 2 defined as FBG \*7\.0 mmol/l or use of diabetes medication
  • \- Participation in any other studies involving the investigation of medication or nutritional products or antibiotic use in the two weeks prior to entry into the study
  • \- HIV/Hepatitis
  • \- Expectation of non\-compliance to the study protocol, among others, a fear of needles
  • \- Known allergies or intolerances for nutritional ingredients in the MTT
  • \- Psychological dysfunctions

Outcomes

Primary Outcomes

Not specified

Similar Trials